about
Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunityProteomics in immunity and herpes simplex encephalitis.Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis.Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity.Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiencyInborn errors of anti-viral interferon immunity in humans.Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhoodTLR3 immunity to infection in mice and humansThe proteome of Toll-like receptor 3-stimulated human immortalized fibroblasts: implications for susceptibility to herpes simplex virus encephalitisCrystallization and preliminary X-ray diffraction analysis of the beta subunit Yke2 of the Gim complex from Saccharomyces cerevisiae.Genetic errors of the human caspase recruitment domain-B-cell lymphoma 10-mucosa-associated lymphoid tissue lymphoma-translocation gene 1 (CBM) complex: Molecular, immunologic, and clinical heterogeneity.Extending the clinical horizons of mucosal bacterial vaccines: current evidence and future prospects.Multimarker risk stratification approach at multiple sclerosis onset.New Biological Insights in the Immunomodulatory Effects of Mucosal Polybacterial Vaccines in Clinical Practice.Ibrutinib as an antitumor immunomodulator in patients with refractory chronic lymphocytic leukemia.Naturally occurring Bruton's tyrosine kinase mutations have no dominant negative effect in an X-linked agammaglobulinaemia cellular model.Chronic lymphocytic leukemia: a paradigm of innate immune cross-tolerance.NFκB2/p100 is a key factor for endotoxin tolerance in human monocytes: a demonstration using primary human monocytes from patients with sepsis.Immunodeficiency and CARD-BCL10-MALT1.Actin polymerisation after FCγR stimulation of human fibroblasts is BCL10 independent.Gain-of-function mutation in PIK3R1 in a patient with a narrow clinical phenotype of respiratory infections.A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia.Unexpected Relevant Role of Gene Mosaicism in Primary Immunodeficiency DiseasesIdentification of novel non-pathogenic mutation in SH3 domain of Btk in an XLA patientSimilar percentages in most abundant chronic granulomatous disease autosomal recessive forms in a Spanish cohortHigh frequency in the delay in primary tooth loss in X-linked chronic granulomatous diseaseBruton's tyrosine kinase is not essential for LPS-induced activation of human monocytesKinase activity and XLA phenotypic variability.Measurement of Typhim Vi IgG as a Diagnostic Tool to Determine Anti-polysaccharide Antibody Production Deficiency in ChildrenDouble-strand break repair through homologous recombination in autosomal-recessive BCL10 deficiencyHuman BCL10 Deficiency due to Homozygosity for a Rare AlleleEvaluation of Polysaccharide Typhim Vi Antibody Response as a predictor of Humoral Immunodeficiency in Haematological MalignanciesAnti-CXCR4 Antibody Combined With Activated and Expanded Natural Killer Cells for Sarcoma ImmunotherapyA purely quantitative form of partial recessive IFN-γR2 deficiency caused by mutations of the initiation or second codonToll-like receptor 3 deficiency in autoimmune encephalitis post-herpes simplex encephalitis
P50
Q24306407-E1085FC4-2430-4273-9F2A-A4127C0F0159Q33803165-C9B2D6C0-FC6B-40BB-A1F1-0D53C3FECB31Q34158815-D45FE83E-5CF5-4E32-A3AF-834F3034764FQ35237500-876230BE-54BC-4B7A-B698-1F7B35C34814Q35578631-88B9003C-D008-468A-8CE2-A11AA2C76845Q35759651-42F1C211-98E9-4666-A441-CBE25AC7D547Q36193566-C2724CD7-9F98-49A4-B62E-CE39ADCC6741Q36675252-65A13683-635D-472B-AD9F-198BC8DBDE50Q36807516-36D58B48-6C8C-4DA3-8C27-B45CDF771170Q36812439-F700F757-18F7-4D9B-847B-58D5841C6B85Q36973638-7BC4941A-B0BC-4B86-8915-149CA15E5B89Q38261417-729646E7-95F9-470E-B7E0-7D3237A613B3Q38746684-1F41580F-D3B3-49E6-8A4D-1FFE3996B3CCQ38940638-A5D9D5C5-0B9C-48ED-8390-B609A8ABA210Q38998430-AD176B2A-3878-494B-9BA4-8BFD905AF38BQ40017947-78D66558-F737-4366-9432-E1EF54AFE9B2Q41600142-F4E59ABB-5AB2-411C-B302-1FCBDFA713D1Q41737634-2CC34679-9A69-425B-8F6E-F8CD9F382C55Q43164252-6B912C2A-6FB6-4156-8197-E765302FFB75Q45245783-596DD637-EEE0-4D70-BDE4-4D6E1DE6117AQ51442147-C42B8E6E-9E4B-4A2A-81A4-F4699C30ED83Q54643679-A1889F2C-E13B-40A7-A0F0-0FD3838B40DAQ57066671-0AC959A3-4171-4C5B-9806-E781DF2EB2BEQ57753203-4EEAFAA5-9509-4B7B-859C-82265000671AQ62640264-7B1E47EE-6694-4D3A-BF64-4A15838EFDF0Q62640328-19B3CAC3-4A9C-4A73-B9BE-3B8AFCA27846Q62640362-7A592BC2-D38D-4862-A3DC-BAA9F6C4B457Q62640387-3A93C80B-1D9E-4FB2-9554-F012A40B9457Q64084535-CDECF81C-529F-4D6B-8DF0-FBD870BB4A48Q64388106-C7600D64-C6B0-4F37-A1A6-10C64716D5CFQ89485962-10BC5733-D959-47D1-A7D8-9F894025DB3EQ91415076-5F9D1F6D-253E-4662-A7D6-146629BBCABEQ92712528-6BE33690-F597-4DAD-A9D0-723A344D7628Q92920530-16780BD8-06A1-4CF1-8D85-F65C99EA98E5Q93132318-1D28B039-0242-4335-A8EA-B23F8109CAC3
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rebeca Perez de Diego
@ast
Rebeca Perez de Diego
@en
Rebeca Perez de Diego
@es
Rebeca Perez de Diego
@nl
Rebeca Perez de Diego
@sl
type
label
Rebeca Perez de Diego
@ast
Rebeca Perez de Diego
@en
Rebeca Perez de Diego
@es
Rebeca Perez de Diego
@nl
Rebeca Perez de Diego
@sl
prefLabel
Rebeca Perez de Diego
@ast
Rebeca Perez de Diego
@en
Rebeca Perez de Diego
@es
Rebeca Perez de Diego
@nl
Rebeca Perez de Diego
@sl
P106
P21
P31
P496
0000-0001-8426-8765